Process Development
Process development services support the isolation, purification, and optimisation of large‑molecule drug manufacturing processes. Prolytix provides consultative process development to support efficient biologic development
Prolytix provides process development services for large‑molecule drugs, including downstream purification development, quality control processes, and formulation development support.
Process and product‑related impurities are identified and evaluated to inform decision‑making and implement process improvements. Protocols are developed to reduce the risk of out‑of‑specification results and improve yield.
These services support scale‑up and efficient manufacturing of protein‑based therapeutics.
Brochures
Process development, analytical development, and GMP testing and release services
Explore the analytical and bioanalytical services Prolytix provides to support large molecule drug discovery and development, from product characterization through GMP release. Capabilities include analytical method development, critical quality attribute testing, process development, stability testing, and bioanalytical assays such as pharmacokinetics, anti-drug antibody, neutralizing antibody, potency, and thrombin generation assays. Prolytix also offers GMP-compliant release testing and lifecycle management of critical reagents.
Resource details:
Resource type: Product brochure
Page count: 2
Read time: 3 mins




